Agilent Plays Santa To Multiplicom Investors With Generous ROI

23 Dec 2016

• By Tina Tan

Investors in Belgian molecular diagnostics company Multiplicom are seeing a payoff with a €68m acquisition offer from Agilent.

More from In Vitro Diagnostics